Target intelligence / Profile preview

RNA, U6 small nuclear 116, pseudogene (RNU6-116P)

Target
RNU6-116P
Molecular classification
Other (pseudogene; non-coding RNA-related)
01

Overview

RNA, U6 small nuclear 116, pseudogene (RNU6-116P) is a member of a family of pseudogenes derived from the U6 small nuclear RNA (snRNA) locus. U6 snRNA is a non-coding RNA and an essential part of the spliceosomal machinery responsible for intron excision from pre-mRNA in eukaryotes, but pseudogene copies such as RNU6-116P do not contribute functional RNA and do not participate in splicing[3][2][1]. These pseudogene loci are common in vertebrate genomes and are considered the result of retrotranspositional events, for instance via LINE-1 elements, marking genomic sites of historical retrotransposition[1][4]. While they do not have catalytic or regulatory activity themselves, they provide insights into genome evolution and retrotransposon dynamics, and sometimes are studied for their role as molecular fossils of splicing-related RNA[4]. There are no diseases specifically associated with RNU6-116P, nor are there drugs or biomarkers that target or use this pseudogene. If you are seeking structured information for drug discovery or biotherapeutic targeting, RNU6-116P is not a suitable target because it is a non-functional pseudogene and does not encode a molecule with biological activity, binding site, or signaling property. For the functional relevance, primary research would focus on the parent gene (U6 snRNA) and its core biological roles rather than the pseudogene copy.

Other names
RNU6-116PU6 small nuclear RNA pseudogene 116
02

Biological functions

Other (no known functional biological activity; does not contribute to splicing itself, but the functional U6 snRNA does)
03

Disease associations

Other (no established direct disease association; can be considered a genomic marker for retrotransposition activity)

Beyond the preview

Go deeper on RNA, U6 small nuclear 116, pseudogene (RNU6-116P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 116, pseudogene (RNU6-116P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call